[{"title": "Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Call Highlights: Navigating Financial ... - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZTBQWDlYeER5OUJmQXhDc3AxR3gwUFpqc1c3ZTdhWWZZS1JaeVgwbk5MRGlVa01LYTZvTjhYa2k1SnE5MUNyUkYtUFpDbndDLXB3X3hXSEcydThsSE5WN01ZVU5TSFpiQUlmbXZlS3NBd1dKbzZ6alVFeGNkMXdXa0tRSUh5TjhK?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Call Highlights: Navigating Financial ...</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 07:03:26 GMT"}, {"title": "Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNeDJwRTNLZ0VsazVvOC1KLVJCSExwVmp1czd6U0xJaVVsSWhnQnF3OGZsZmt1RjlTSFQ4MTlfbUJINDNobXJIX0duWjZYV2h5RkhMRzZwWFFUSmtXWmcycXNKSnVOb2dWdHl6VFhFbnVFR1BsY3hVQTZOTzRpYlVqSGc1UHBwUWZTMXVvMXZSSzlSc0kyZndESmRJSC1yMDNIdFd3X01RMW8?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc. SEC 10-Q Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>", "publishedAt": "Mon, 11 Aug 2025 11:43:00 GMT"}, {"title": "Karyopharm Therapeutics Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:KPTI) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNM2x6aDVfTzlXR1dadkZDX0RRNW82YWo5VzYtMTVxNk40OWFfTVJmU3pOZi1nOHF1d2FKR1BsY0ZOUWVuSTNpdXhRVnVLT3c4TUcxam1CaVh1dTlnU2tmVTZ1NGNRWDFsVUNmOE9ONTZHSk4xMGJiWlQzRHpKcHRFM0FnRkVEamJpU3BObTE4NVF3NmNfLXIzbERwemszTWdNRWpuam8xeUE1Ym9Tek45WQ?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:KPTI)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Mon, 11 Aug 2025 15:03:53 GMT"}, {"title": "US$25.92: That's What Analysts Think Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Is Worth After Its Latest Results - simplywall.st", "description": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">US$25.92: That's What Analysts Think Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Is Worth After Its Latest Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>", "publishedAt": "Thu, 14 Aug 2025 12:01:57 GMT"}, {"title": "Karyopharm Therapeutics: Q2 Earnings Snapshot - CTPost", "description": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOS2FMV1M2YkNEd3VqV0ZodmlMOC05NkFGbHFFQlFFdWJRSjVRV0hUWURXNVkwOWliemZUSlRiQ21aSEZONlFST1pYS2VMeDE4YlRVV2lmbnNxNTJyU3JlMEtSejhhTGpNQW15ZF91TnA4VEUzbGVuYnBQa3VZbFU0a3NHMXk5bXNfdmFKOWdXTTVhNmFPMDV6UkxDNWZIZw?oc=5\" target=\"_blank\">Karyopharm Therapeutics: Q2 Earnings Snapshot</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CTPost</font>", "publishedAt": "Tue, 12 Aug 2025 10:40:26 GMT"}, {"title": "Karyopharm Therapeutics: Q2 Earnings Snapshot - Stamford Advocate", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNUV9vOTNkTlJLT21MRzJWUVJCbDF5SktENXN4N0tIQ2J0TTBMakprWk9iNkM1U3R1M3ZLal9tUlFqN09GQUZ2d2d3WFBheGs0NGR4ZExyalU0b05CZ0tTWmVxRGdFQWdVY3RlTUNodWdtaERDLV9mNGUwNmdIbkJ0cnVsZnVQb2dnT2VLbzVIS1FWbEVRdVZHSS1FZDNxNXVrcnp4cWljQ29UVXc?oc=5\" target=\"_blank\">Karyopharm Therapeutics: Q2 Earnings Snapshot</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stamford Advocate</font>", "publishedAt": "Tue, 12 Aug 2025 08:14:28 GMT"}, {"title": "Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q2 2025 Earnings Call Transcript - Insider Monkey", "description": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxPTS1KakRVVnZjWXVvMUg1QVVsT3RuQy1lTEFPWkQ2U21UYmJteTI1ZDhoYWJyZGRlS1NqVkxaaDBUT3ZJUExOYWxmZm8zeEV0SDVJclVyYmREUHNpU2dYT0xFZDlLUW5QeXd1eVZwVEN0VWxTeVR4WFVaeTRCUnlZcGctNkp0UFJKcGl2MXZJM0xhcExhRlpHVE1nZmJpdmM1MDFKSmViY0dlRGZNRGs3VXZiTkk?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q2 2025 Earnings Call Transcript</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Insider Monkey</font>", "publishedAt": "Wed, 13 Aug 2025 12:24:37 GMT"}, {"title": "Karyopharm Therapeutics\u2019 SWOT analysis: biotech firm\u2019s stock faces pivotal year - Investing.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMizwFBVV95cUxPVXJBcXY4XzgtYVQ3Z21qdkJfM2N6NDBvUDZvODF6T0VJRmhuUGJOS2EwY1EwZ21MUjh2NlVqYmtuMjh0bWI5ZFhHQ0lRM3hlQlc4ZnNSYTQ2WlRSclJTSFJoMVI4VGFOYU9JY0lLYVBWUnMybTJ6Zm1iNWR1VXJsR0FVa3BQMGdPTTMyYkprSDFxSU5BOTVVUDV6ZkNzNHVaNHFLZXhaSDVMUnptRTM3SFZjaTFRcVNnbnBNeDdxN19GUDZDdFpUZ1Q2N2F6Umc?oc=5\" target=\"_blank\">Karyopharm Therapeutics\u2019 SWOT analysis: biotech firm\u2019s stock faces pivotal year</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>", "publishedAt": "Wed, 13 Aug 2025 20:04:36 GMT"}, {"title": "Karyopharm Therapeutics Sees $1B Peak Revenue Potential in Myelofibrosis by 2026 - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMirAFBVV95cUxOVHRZM0RJTmhfbEhHY1NfMEltRU5FU0RudlVORWt5YjluYVZDRzkzbDMtSDhkZUpHekFFUklxYmh0WkNqYVQ3QkRpRDdEQUxtbDloYWxFOC1GSVhUdjJLYmJmYjhPWkdsM3Q4RkRMc0JWMndsa2lJMHFYUEtnS1V0dzM1SEUtU2pETjF0Q2lPM0hBMFZ0WU53TU9JUnFOclVjQ0pXSVpFdDdYaGpp?oc=5\" target=\"_blank\">Karyopharm Therapeutics Sees $1B Peak Revenue Potential in Myelofibrosis by 2026</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Mon, 11 Aug 2025 15:19:42 GMT"}, {"title": "Karyopharm Therapeutics Reports Q2 2025 Earnings - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxQWTNqVU5lSG43ZzFnQ3ZvMnJtWGRLb3J4RDZ1SEhRbXcweWNpV2xEeFRDMFNIMmJOeWVWT1RFa0pDTGdMYlhxcVVxWHlOX3kzNDBManZ5VFNmcjNEZjFwRUNDNXFlUkRDQTNEWEJMaWlRR1NhTWx2QTRnRkNQeDVqZ0EwcG9hZ1otWlo2MDYwX2xFcDBoaFRjWVdVXzRjWXRNZFE?oc=5\" target=\"_blank\">Karyopharm Therapeutics Reports Q2 2025 Earnings</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Tue, 12 Aug 2025 04:10:55 GMT"}, {"title": "Karyopharm Therapeutics: Q2 Earnings Snapshot - Barchart.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxOQUIyOThGRWRKUGNlQ0VxcjQ5c3pGTWNPaUQ1dTJJSE5SQmxYeUZkb1JEbVRBYnNTdFMyaWVWZFVTSDkzQWhiZ0hWellsQXo1UDZYajM3VlEyeFVwbTh0LVA5M2FHbTJ0WGRCR3pfaUJVRjdYeHBZQ29yQzV1bXhOQkd3ZFplSXppeTJnYWczMDk5bDQ?oc=5\" target=\"_blank\">Karyopharm Therapeutics: Q2 Earnings Snapshot</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barchart.com</font>", "publishedAt": "Mon, 11 Aug 2025 21:57:13 GMT"}, {"title": "Karyopharm Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView", "description": "<a href=\"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQd1F1alF6dFRxUUU1ZFdPaFJDNWcyaGVFRWpfaGRIRWQ1eEtUYm9XVkpERTFfTzYtaC1EeWd4bEw4cklWb2JacDNhenFwOG1MZEtQRVRUdDQ1MXBkN2hGekJ5c2NzZjRpWGVGcUZ6UVIySzVnTGF5ZU9kdkxVTlZBQWZ2Qk1rNE4yNW9yT01pdkU1QnR2V1E4REZMWC1yNlF1OVppZW5jYkhwTmpNMGh2YjgtaU94Yl9jTW42Njh0ZnhtcE90T1dPSXNGNE9FQmZWS2JJLW42VHRRX0o3YVVXZXc3MlBLd3RGY2xveU1BaVJzQQ?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>", "publishedAt": "Mon, 11 Aug 2025 13:31:56 GMT"}, {"title": "Karyopharm Therapeutics shares rise 1.03% premarket after reporting Q2 earnings. - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNXzkwMVFRUFZCNGtFVGtsb2VubWpWVlF4R1paaFlaZ1lQY29tc0lfaHdmbmQ4emdzWUp3ZVU0ZDNHWEJUR1lkRXVWdXJWaUlqeDExTVRfSFVjRW5TaDFwTEIwS1Y0X3dQQVVWSDI4SmxsWGFKQlJOOWp0UWQxQ1NsMC1oSHdwRFdvYjZDNzRwTnloUC1aUUNsc3I2emFSOS1nZ1R5SE9obGEtUGs?oc=5\" target=\"_blank\">Karyopharm Therapeutics shares rise 1.03% premarket after reporting Q2 earnings.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Tue, 12 Aug 2025 13:10:47 GMT"}, {"title": "Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Call Highlights: Navigating Financial ... By GuruFocus - Investing.com Canada", "description": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNOXJNZTNZREdvQUdsbjBTemtiLXFrdW9zU2gtdEZCYUxXSEx3SWVXM24yVzVlVmotQkZfSzlqblM5d3lZaHNlbnJaNDd0MkJJZFQxajItQmxCVVZRRkF2SGpzWVllQUctQU5IVDBieEZZRC1ETEZLbmRCN3dkNThpT2diN3lEM3I4VU9ZbkZxSVYtQWI0amZRLUVfTGlGYXVnRXcxUmUzMjY2ZkJoUVNyMmRzQzJ5QURJYmNZY3hmQ2FHUFVvVWVIbDlVRXdZVHFZZ3BiZQ?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Call Highlights: Navigating Financial ... By GuruFocus</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com Canada</font>", "publishedAt": "Tue, 12 Aug 2025 06:33:45 GMT"}, {"title": "Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxPczAtVnhSZEhrNktfT1ZDQ3pWcndXVGhZN3BYLVc5UWFRbUhqUDZqclVmOHF5aEZ2MF9Kc3RoWktuc3VtdTJmWndOY3lPaTBYNm1wOXVrVlVYbC1ET3dVeU1EaHpEaURLajNJVXBSNFlWUlVMYy1ybDN1TXNfWnVaaG9RV3NmRktiT1lORldn?oc=5\" target=\"_blank\">Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Mon, 11 Aug 2025 23:00:03 GMT"}, {"title": "Karyopharm Therapeutics Q2 EPS Misses Estimate, Revenue Down 11.4% Y/Y - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxNV3pPVlVxbmdqVHFLWVg2TFhDc1hXcC1Qb05BSGJlQk9pdWZoVVJodnA4NFcyMlMzSVRWMWZsa3NEUWhSTm4tNTMtUVRmelZ3a0ZBYzlqZlFhZUJwVWpxVUZ2SEtQU19yM0o1c1NxeGJuLTlrWEh6TTdlaGw0VGZBU1JSRnBrcTNDc2h4RXpGcEFzRXlHcUk4VUt3?oc=5\" target=\"_blank\">Karyopharm Therapeutics Q2 EPS Misses Estimate, Revenue Down 11.4% Y/Y</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Mon, 11 Aug 2025 11:34:03 GMT"}, {"title": "Karyopharm Therapeutics Q2 revenue falls 11% - MarketScreener", "description": "<a href=\"https://news.google.com/rss/articles/CBMinAFBVV95cUxON2dqQVowMnc5b0FHMWUtc3dEZGFqQlU0X25nZkpOZS1oT29NenNYajItQnRpMGJTZGNkTEJ2NGt1RW01ellGVHBRdU1ZVXJ3cVRrZmg1OTVCTkkyWHFDdGdoaEN0U2Jfa0ZiLVE4M2ZLTEQxc3hzVEJJMS1ldXNOT2wtSkpWODdpSDQyOEpicndEZWRaZEphMXdPU1M?oc=5\" target=\"_blank\">Karyopharm Therapeutics Q2 revenue falls 11%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>", "publishedAt": "Mon, 11 Aug 2025 11:43:15 GMT"}, {"title": "Karyopharm Therapeutics Inc. stock prediction for this week - Portfolio Growth Summary & Expert Approved Momentum Ideas - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPREdWU2I3Q2NGdHdGYmFsQnBCcVhxcWE3Sldwa19pY1NXTkNuVUNLSDZ4ZVR1RTEwRlBJczB1NWg3QlVuejRqcjdLaXg0VzRHakFlNklFcmdkUkpJYmt3aUF5RW9fRGlPb0NwSS0zZjZFWG1IRTIwZTdDZVdycm83a3d3bDh4ZHIxN3NUZnFkdDgyWUc4SG14Ng?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc. stock prediction for this week - Portfolio Growth Summary & Expert Approved Momentum Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Wed, 13 Aug 2025 02:58:06 GMT"}, {"title": "How Karyopharm Therapeutics Inc. stock reacts to Fed policy changes - Earnings Recap Report & Weekly High Conviction Ideas - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxNNlhuUno0bXd3TUdib3NQMlMwTEZscVcxYXIwR1BVU3ZiY2V0X3V4TWFoWkg3dkVYQnhIdUNDaHJOMmRYenVsVTBHdUlHUHRkRFE3Q2l3MlRnT1B5YlhmVVM5ZFhKa2JOVXkyem4yelBHR2ZwdXdNXzVmVlFiQWM2TW9zZkRGOXFEekVsY0FZWXpiaGNqSldrVnNYQVVNUQ?oc=5\" target=\"_blank\">How Karyopharm Therapeutics Inc. stock reacts to Fed policy changes - Earnings Recap Report & Weekly High Conviction Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Fri, 15 Aug 2025 11:05:06 GMT"}, {"title": "What makes Karyopharm Therapeutics Inc. stock price move sharply - Value Investing Checklist with Entry Signals - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxNeWZGMjItc0hlaVlRWlRhSXljWkZvemVyNFl5Y21tRXhoRUJyQ2lNR09wWXNwajBkaHNaRDk1Q0VIaXVNZFhpSVBfQm01a19iMEJZb1dQd3BYemFkaURQQXhyNlZCSHZzd1dubnViLXRTMU1RU2FKUkVDTTQ0Q0JxSDJxRXBuYjFJWlh3WUJka1o1SXdXVGlFME1Hdw?oc=5\" target=\"_blank\">What makes Karyopharm Therapeutics Inc. stock price move sharply - Value Investing Checklist with Entry Signals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sun, 10 Aug 2025 03:09:07 GMT"}, {"title": "Can Karyopharm Therapeutics Inc. rally from current levels - 2025 Retail Activity & Weekly Stock Breakout Alerts - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxPYmI5Z0RsbXoxUmc4V2FyNEVGNVQtUWs3R2xzTHR5ZzN1ZXBCMnlLMjZNZkhFaTRpTDU5elRrWFRQcHowLTdjUDd5ZEpnUFNBWFg2eWJyNGFfcHFwUlBCWVo1SmZfVU9fSDBNN3R4RVdqZ25SNERBd05SYThpUWJwZ1RDbW1HZkQ3dW5jb2tYdmR6amJvMkE?oc=5\" target=\"_blank\">Can Karyopharm Therapeutics Inc. rally from current levels - 2025 Retail Activity & Weekly Stock Breakout Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Wed, 13 Aug 2025 07:12:30 GMT"}, {"title": "Karyopharm Therapeutics (NASDAQ:KPTI) Given New $25.00 Price Target at Robert W. Baird - Defense World", "description": "<a href=\"https://news.google.com/rss/articles/CBMixAFBVV95cUxNa1pHamdaaHJGQmUyQkZlRmtpYWdHT0dzblg2RFVfRDhlY04yaVZfcl90MHVoRmMyeWRlbFc2T2N4SDBHNnRFN19seVRNMGNfS1FOTmNaMDJFMVZBUjFlU3dSYXpaOWh0TVVKUF9Dd0I0NEVmYTRydGxzMWV4Vllyc010cWZLQWhNa29qdG1JM3h3VnpGcmtIdmcwYnlxbkdFOHE0bUVETVByQXBoakhZYkVhY282ZGw4UV9leXprazF0RXA2?oc=5\" target=\"_blank\">Karyopharm Therapeutics (NASDAQ:KPTI) Given New $25.00 Price Target at Robert W. Baird</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Defense World</font>", "publishedAt": "Wed, 13 Aug 2025 06:43:00 GMT"}]